GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
GEVA
Delisted
GEVA was delisted on the 22nd of June, 2015.
126 hedge funds and large institutions have $3.37B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 120 → 126 (+6)
24% less call options, than puts
Call options by funds: $9.78M | Put options by funds: $12.9M
Holders
126
Holding in Top 10
3
Calls
$9.78M
Puts
$12.9M
Top Buyers
| 1 | +$65.1M | |
| 2 | +$44.9M | |
| 3 | +$10.5M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$8.26M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$7.47M |
Top Sellers
| 1 | -$22.1M | |
| 2 | -$13.3M | |
| 3 | -$9.77M | |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$7.42M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
-$5.85M |